Skip to content

Study for the diagnosis of techniques of typical TCM syndromes of non-small cell lung cancer

Study for the diagnosis of techniques of typical TCM syndromes of non-small cell lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021520
Enrollment
Unknown
Registered
2019-02-25
Start date
2018-01-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer

Interventions

Bian-Zhen,&#32
criptionomics,&#32
macrogenomics,&#32
proteomics

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Histological confirmation for lung adenocarcinoma; 2. Patients who had not received surgery, radiotherapy, chemotherapy, targeted therapy, biological therapy, traditional Chinese medicine or any other tumor-related treatment are initially treated; 3. Life expectancy at least 6 months; 4. Aged 18-75 years; 5. KPS=60 or PS 0-2; 6. Diagnosed as qi and Yin deficiency, qi deficiency phlegm dampness or qi and blood stasis syndrome; 7. Agree and sign the informed consent; 8. Good compliance with study and follow-up procedures; 9. accessory examination;bilirubin 1.5ULN (ULN is the upper limit of normal value), ALT, AST 2.5ULN, (liver metastasis 5ULN);Renal function: serum creatinine 1.5uln;Bone marrow reserves: blood routine: WBC 4*10^9/L or higher, neutrophils 2*10^9/L or higher, the platelet 100*10^9 / L, 100 g/L or higher hemoglobin.

Exclusion criteria

Exclusion criteria: 1. Other primary malignancies; 2. Having other primary malignancies and having any unstable systemic disease (including peptic ulcers, active infections, grade iv hypertension, unstable angina, congestive heart failure, systemic lupus erythematosus or fractures, wounds that have not healed); 3. Having serious systemic diseases of endocrine, cardiovascular, blood, liver and kidney; 4. Pregnant and lactating women and patients with mental disorders; 5. patients have been treated with antibiotics and suffered from acute or chronic intestinal inflammation, diabetes, obesity, food allergy and other diseases that affect the structure of intestinal flora in last month; 6. plan to participate in other clinical research trials or being engaged in clinical research trials.

Design outcomes

Primary

MeasureTime frame
syndrome differentiation;transcriptomics;Metagenomics;proteomics;

Countries

China

Contacts

Public ContactChai Kequn

Tongde Hospital of Zhejiang Province

ckq3301@aliyun.com+86 13906503739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026